A detailed history of Heartland Bank & Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Heartland Bank & Trust CO holds 4,774 shares of LLY stock, worth $4.32 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares
4,774
Previous 4,958 3.71%
Holding current value
$4.32 Million
Previous $2.89 Million 28.48%
% of portfolio
2.21%
Previous 1.99%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 17, 2024

SELL
$592.2 - $792.28 $108,964 - $145,779
-184 Reduced 3.71%
4,774 $3.71 Million
Q4 2023

Jan 23, 2024

SELL
$525.19 - $619.13 $73,526 - $86,678
-140 Reduced 2.75%
4,958 $2.89 Million
Q3 2023

Oct 12, 2023

SELL
$434.7 - $599.3 $182,139 - $251,106
-419 Reduced 7.59%
5,098 $2.74 Million
Q2 2023

Jul 19, 2023

SELL
$350.74 - $468.98 $268,666 - $359,238
-766 Reduced 12.19%
5,517 $2.59 Million
Q1 2023

Apr 17, 2023

SELL
$310.63 - $364.82 $128,911 - $151,400
-415 Reduced 6.2%
6,283 $2.16 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $330,231 - $384,786
-1,027 Reduced 13.29%
6,698 $2.45 Million
Q3 2022

Oct 11, 2022

BUY
$296.48 - $337.87 $149,425 - $170,286
504 Added 6.98%
7,725 $2.5 Million
Q2 2022

Jul 12, 2022

BUY
$278.73 - $327.27 $37,628 - $44,181
135 Added 1.91%
7,221 $2.34 Million
Q1 2022

Apr 12, 2022

SELL
$234.69 - $291.66 $287,495 - $357,283
-1,225 Reduced 14.74%
7,086 $2.03 Million
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $1,349 - $1,674
6 Added 0.07%
8,311 $2.3 Million
Q3 2021

Oct 18, 2021

BUY
$221.6 - $272.71 $1.07 Million - $1.32 Million
4,840 Added 139.68%
8,305 $1.92 Million
Q2 2021

Jul 30, 2021

SELL
$180.55 - $233.54 $14,624 - $18,916
-81 Reduced 2.28%
3,465 $795,000
Q4 2020

Jun 15, 2021

BUY
$130.46 - $172.63 $462,611 - $612,145
3,546 New
3,546 $599,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Heartland Bank & Trust CO Portfolio

Follow Heartland Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Bank & Trust CO with notifications on news.